We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Here's Why ENSG Shares Are Attracting Prudent Investors Now
Read MoreHide Full Article
Key Takeaways
ENSG shares have climbed 23.8% in a year, outpacing the industry's 17.3% average growth.
Earnings and revenue estimates for 2025 rose, with revenues now guided at up to $4.94 billion.
Low debt, buybacks and dividends show ENSG's commitment to boosting shareholder value.
The Ensign Group Inc. (ENSG - Free Report) is a healthcare services company that provides services in the post-acute care continuum, urgent care centers and mobile ancillary businesses in the United States. The company operates through two reportable segments: Skilled Services and Standard Bearer. ENSG has risen 23.8% in the past year, outperforming the industry’s average growth of 17.3%.
Headquartered in San Juan Capistrano, CA, ENSG holds a market capitalization of $8.7 billion. It is also engaged in the acquisition, development and leasing of skilled nursing, and provides senior living services. Its forward P/E ratio of 23.01X is lower than the industry average of 45.06X.
Courtesy of solid prospects, ENSG currently carries a Zacks Rank #2 (Buy).
Where Do Estimates for ENSG Stand?
The Zacks Consensus Estimate for The Ensign Group’s 2025 earnings is pegged at $6.29 per share, indicating a 14.4% year-over-year rise. In the past 60 days, it has witnessed three upward estimate revisions against none in the opposite direction. Furthermore, the consensus mark for revenues is pegged at $4.9 billion for 2025, implying a 15% year-over-year rise. It beat earnings estimates in each of the past four quarters, with an average surprise of 1.6%.
The Ensign Group’s revenues have grown over the past few years, primarily driven by service revenues, strategic acquisitions and rental income. The combination of improvements in occupancy and skilled mix in its operations and long-term growth in acquired operations shows organic growth potential. It aims to continue its optimization of operational efficiencies, expand services and create new partnerships, which will drive further improvements in occupancy and skilled mix. Since 2024, the company has added 47 new operations across several markets.
ENSG’s skilled services unit’s revenues witnessed 15.9% year-over-year growth in the first quarter of 2025 to $1.12 billion. Its standard bearer segment’s revenues grew 27.9% year over year to $28.4 million in the same quarter. The company increased its 2025 annual revenue guidance range to $4.89-$4.94 billion from $4.83-$4.91 billion.
Its total debt is 7% of its capital, much lower than the industry’s average of 86.2%. The Ensign Group bought back shares worth $10.8 million in the first quarter of 2025. During the same time frame, the company paid dividends worth $3.6 million. This highlights its shareholder value-boosting efforts.
ENSG: Risks to Watch
There are some factors, however, that investors should keep a careful eye on.
The company’s total expenses have escalated over the last several years due to higher costs of services and rent. Total expenses witnessed a year-over-year increase of 27.3% in 2023, 12.3% in 2024 and 15.5% in the first quarter of 2025. The persistent escalation of expenses might weigh on its margin growth. ENSG’s free cash flow is volatile in nature, which decreased 23.8% year over year in the first quarter of 2025.
The Zacks Consensus Estimate for Encompass Health’s current-year earnings of $5.01 per share has witnessed eight upward revisions in the past 60 days against no movement in the opposite direction. Encompass Health beat earnings estimates in each of the trailing four quarters, with the average surprise being 12.3%. The consensus estimate for current-year revenues is pegged at $5.9 billion, suggesting 9.5% year-over-year growth.
The Zacks Consensus Estimate for GeneDx Holdings’ current-year earnings of $1.09 per share has witnessed one upward revision in the past 60 days against no movement in the opposite direction. GeneDx Holdings beat earnings estimates in each of the trailing four quarters, with the average surprise being 145.8%. The consensus estimate for current-year revenues is pegged at $374.1 million, suggesting 22.5% year-over-year growth.
The Zacks Consensus Estimate for Integer Holdings’ current-year earnings of $6.33 per share has witnessed one upward revision in the past 30 days against no movement in the opposite direction. Integer Holdings beat earnings estimates in three of the trailing four quarters and missed once, with an average surprise being 2.8%. The consensus estimate for current-year revenues is pegged at $1.9 billion, suggesting 7.7% year-over-year growth.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Here's Why ENSG Shares Are Attracting Prudent Investors Now
Key Takeaways
The Ensign Group Inc. (ENSG - Free Report) is a healthcare services company that provides services in the post-acute care continuum, urgent care centers and mobile ancillary businesses in the United States. The company operates through two reportable segments: Skilled Services and Standard Bearer. ENSG has risen 23.8% in the past year, outperforming the industry’s average growth of 17.3%.
Headquartered in San Juan Capistrano, CA, ENSG holds a market capitalization of $8.7 billion. It is also engaged in the acquisition, development and leasing of skilled nursing, and provides senior living services. Its forward P/E ratio of 23.01X is lower than the industry average of 45.06X.
Courtesy of solid prospects, ENSG currently carries a Zacks Rank #2 (Buy).
Where Do Estimates for ENSG Stand?
The Zacks Consensus Estimate for The Ensign Group’s 2025 earnings is pegged at $6.29 per share, indicating a 14.4% year-over-year rise. In the past 60 days, it has witnessed three upward estimate revisions against none in the opposite direction. Furthermore, the consensus mark for revenues is pegged at $4.9 billion for 2025, implying a 15% year-over-year rise. It beat earnings estimates in each of the past four quarters, with an average surprise of 1.6%.
The Ensign Group, Inc. Price and EPS Surprise
The Ensign Group, Inc. price-eps-surprise | The Ensign Group, Inc. Quote
ENSG’s Growth Drivers
The Ensign Group’s revenues have grown over the past few years, primarily driven by service revenues, strategic acquisitions and rental income. The combination of improvements in occupancy and skilled mix in its operations and long-term growth in acquired operations shows organic growth potential. It aims to continue its optimization of operational efficiencies, expand services and create new partnerships, which will drive further improvements in occupancy and skilled mix. Since 2024, the company has added 47 new operations across several markets.
ENSG’s skilled services unit’s revenues witnessed 15.9% year-over-year growth in the first quarter of 2025 to $1.12 billion. Its standard bearer segment’s revenues grew 27.9% year over year to $28.4 million in the same quarter. The company increased its 2025 annual revenue guidance range to $4.89-$4.94 billion from $4.83-$4.91 billion.
Its total debt is 7% of its capital, much lower than the industry’s average of 86.2%. The Ensign Group bought back shares worth $10.8 million in the first quarter of 2025. During the same time frame, the company paid dividends worth $3.6 million. This highlights its shareholder value-boosting efforts.
ENSG: Risks to Watch
There are some factors, however, that investors should keep a careful eye on.
The company’s total expenses have escalated over the last several years due to higher costs of services and rent. Total expenses witnessed a year-over-year increase of 27.3% in 2023, 12.3% in 2024 and 15.5% in the first quarter of 2025. The persistent escalation of expenses might weigh on its margin growth. ENSG’s free cash flow is volatile in nature, which decreased 23.8% year over year in the first quarter of 2025.
Other Key Picks
Some other top-ranked stocks in the Medical space are Encompass Health Corp (EHC - Free Report) , GeneDx Holdings Corp (WGS - Free Report) and Integer Holdings Corporation (ITGR - Free Report) , each sporting a Zacks Rank #1 (Strong Buy) at present. You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for Encompass Health’s current-year earnings of $5.01 per share has witnessed eight upward revisions in the past 60 days against no movement in the opposite direction. Encompass Health beat earnings estimates in each of the trailing four quarters, with the average surprise being 12.3%. The consensus estimate for current-year revenues is pegged at $5.9 billion, suggesting 9.5% year-over-year growth.
The Zacks Consensus Estimate for GeneDx Holdings’ current-year earnings of $1.09 per share has witnessed one upward revision in the past 60 days against no movement in the opposite direction. GeneDx Holdings beat earnings estimates in each of the trailing four quarters, with the average surprise being 145.8%. The consensus estimate for current-year revenues is pegged at $374.1 million, suggesting 22.5% year-over-year growth.
The Zacks Consensus Estimate for Integer Holdings’ current-year earnings of $6.33 per share has witnessed one upward revision in the past 30 days against no movement in the opposite direction. Integer Holdings beat earnings estimates in three of the trailing four quarters and missed once, with an average surprise being 2.8%. The consensus estimate for current-year revenues is pegged at $1.9 billion, suggesting 7.7% year-over-year growth.